Senior insider sale
AXSOME THERAPEUTICS, INC. — senior position signals high conviction
$4.03M
25K shares
What this filing means
COLEMAN MARK plans to sell 25K shares of AXSOME THERAPEUTICS, INC. valued at approximately $4.03M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/26/2026ACC: 0001921094-26-000210
25K
Shares to sell
$4.03M
Approx. market value
25K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Exercise and Hold
Cash
1/3/2025
9.13KExercise and Hold
Cash
11/19/2024
12.87KExercise and Hold
Cash
1/3/2023
3KTotal acquired25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2025 | Exercise and Hold Cash | 9.13K | — |
11/19/2024 | Exercise and Hold Cash | 12.87K | — |
1/3/2023 | Exercise and Hold Cash | 3K | — |
| Total | 25K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
25K
Market value
$4.03M
2/26/2026
Total
Units
25K
Value
$4.03M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/26/2026 | 25K | $4.03M | NASDAQ | Planned |
| Total | 25K | $4.03M | ||